CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion

In December 2017, ESMO Open—Cancer Horizons convened a round-table discussion on the background and latest data regarding cyclin-dependent kinase (CDK)4/6 inhibitors with endocrine therapy (ET) in the treatment of endocrine-sensitive breast cancer (BC). A review on this discussion was published in s...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Christoph Zielinski, Ahmad Awada, Joseph Gligorov, Guy Jerusalem, Christian Singer
Fformat:	Erthygl
Iaith:	English
Cyhoeddwyd:	Elsevier 2019-11-01
Cyfres:	ESMO Open
Mynediad Ar-lein:	https://esmoopen.bmj.com/content/4/6/e000565.full

Eitemau Tebyg

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
gan: Philipp Harter, et al.
Cyhoeddwyd: (2020-12-01)

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
gan: Van Cutsem, E, et al.
Cyhoeddwyd: (2016)

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series
gan: Christoph C Zielinski
Cyhoeddwyd: (2019-06-01)

ESMO gynaecological cancers congress 2024
gan: Elena Bellafante
Cyhoeddwyd: (2024-08-01)

Highlights in Prostate Cancer from ESMO 2021
gan: Ursula Vogl
Cyhoeddwyd: (2021-12-01)

Highlights in Gynecological Cancer from ESMO 2021
gan: Christian Kurzeder
Cyhoeddwyd: (2021-12-01)

ESMO Open: news in breast cancer 2019
gan: Daniele Santini, et al.
Cyhoeddwyd: (2020-05-01)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
gan: Muro, Kei, et al.
Cyhoeddwyd: (2019)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
gan: Muro, Kei, et al.
Cyhoeddwyd: (2019)

The latest progress of breast cancer treatment at 2023 ESMO
gan: ZHOU Teng, ZHANG Jian
Cyhoeddwyd: (2023-11-01)

The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010.
gan: Van Cutsem, E, et al.
Cyhoeddwyd: (2011)

The diagnosis and management of gastric cancer: Expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010
gan: van Cutsem, E, et al.
Cyhoeddwyd: (2011)

Correction: CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion
gan: Joris van de Haar, et al.
Cyhoeddwyd: (2019-04-01)

Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines†
gan: Sara Booth, et al.
Cyhoeddwyd: (2020-12-01)

PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS:H) VERSION 1.0
gan: Barbara Kiesewetter, et al.
Cyhoeddwyd: (2023-08-01)

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
gan: Eckel, F, et al.
Cyhoeddwyd: (2011)

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
gan: Eckel, F, et al.
Cyhoeddwyd: (2010)

A wind of change in upper gastrointestinal cancers: updates from ESMO 2023
gan: A. Cammarota, et al.
Cyhoeddwyd: (2024-03-01)

ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer
gan: Silvia Catanese
Cyhoeddwyd: (2020-11-01)

ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
gan: Enriqueta Felip, et al.
Cyhoeddwyd: (2020-11-01)

ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer
gan: Fatima Cardoso, et al.
Cyhoeddwyd: (2020-11-01)

ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer
gan: George Pentheroudakis, et al.
Cyhoeddwyd: (2020-11-01)

Highlights of the ESMO Asia Congress 2024
gan: Jiefang Huang
Cyhoeddwyd: (2025-02-01)

Educational needs in gastrointestinal cancer: a consensus position paper from the ESMO Gastrointestinal Cancer Faculty
gan: Josep Tabernero, et al.
Cyhoeddwyd: (2019-06-01)

ESMO Congress 2021 News: Update Systemic Therapy in Early and Advanced Breast Cancer
gan: Marcus Vetter, et al.
Cyhoeddwyd: (2021-10-01)

Progress in clinical management of cancer of unknown primary based on molecular testing at 2023 ESMO
gan: ZHANG Xiaowei, LIU Xin, LUO Zhiguo
Cyhoeddwyd: (2023-11-01)

Vascular Inflammation and Cardiovascular Burden in Metastatic Breast Cancer Female Patients Receiving Hormonal Treatment and CDK 4/6 Inhibitors or Everolimus
gan: Christos Papageorgiou, et al.
Cyhoeddwyd: (2021-02-01)

ESMO 2024: the rise of antibody conjugated drugs
gan: Elena Bellafante
Cyhoeddwyd: (2024-12-01)

ESMO pays tribute to Professor José Baselga
gan: S. Peters, et al.
Cyhoeddwyd: (2021-03-01)

New Horizons In The Treatment Of Metastatic Castrate Resistant Prostate Cancer
gan: Zein El Amir
Cyhoeddwyd: (2023-06-01)

Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A Podcast
gan: Alex Filicevas, et al.
Cyhoeddwyd: (2023-06-01)

Care of adolescents and young adults with cancer in Asia: results of an ESMO/SIOPE/SIOP Asia survey
gan: Chi Kong Li, et al.
Cyhoeddwyd: (2019-06-01)

Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer
gan: Paul E. Hanna, et al.
Cyhoeddwyd: (2023-08-01)

European Society for Medical Oncology (ESMO) congress 2024
gan: Daniela Marín-Hernández, et al.
Cyhoeddwyd: (2024-11-01)

Hodgkin Lymphoma: Comments on ESMO Clinical Practice Guidelines
gan: Igor Aurer, et al.
Cyhoeddwyd: (2020-08-01)

ESMO Updates the Guidelines for the Diagnosis of *RET*-Altered Cancer to Herald a New Era in Targeted Therapy
gan: Alfredo Addeo, et al.
Cyhoeddwyd: (2021-06-01)

Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer
gan: Tiphaine de Foucher, et al.
Cyhoeddwyd: (2018-05-01)

ESMO Updates the Guidelines for the Diagnosis of RET-Altered Cancer to Herald a New Era in Targeted Therapy
gan: Alfredo Addeo, et al.
Cyhoeddwyd: (2021-06-01)

ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy
gan: Hendrik-Tobias Arkenau, et al.
Cyhoeddwyd: (2020-05-01)

Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer
gan: Nicholas Mai, et al.
Cyhoeddwyd: (2024-10-01)